There is evidence linking RANTES with metabolic syndrome and IL-6 [27], which in turn is directly related to endothelial dysfunction and therefore to an increased risk of HT and cardiovascular events, possibly having an important role in the progression of atherosclerosis [28]. This evidence concerns the gene IL6 and hematocrit.